{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:11:00Z","timestamp":1790626260844,"version":"4.1.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2013]]},"DOI":"10.4103\/0253-7613.121390","type":"journal-article","created":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T04:12:50Z","timestamp":1384402370000},"page":"638","source":"Crossref","is-referenced-by-count":11,"title":["Pregabalin-induced self-harm behavior"],"prefix":"10.4103","volume":"45","author":[{"given":"VishalR","family":"Tandon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZahidH","family":"Gillani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annil","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.121390-1","first-page":"95","volume-title":"Pregabalin for pain management","author":"Gajraj","year":"2005","journal-title":"Pain Pract"},{"key":"key-10.4103\/0253-7613.121390-2","first-page":"947","volume-title":"A signal for an abuse liability for pregabalin--results from the Swedish spontaneous adverse drug reaction reporting system","author":"Schwan","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"key-10.4103\/0253-7613.121390-3","first-page":"95","volume-title":"Adjunctive pregabalin in partial responders with major depressive disorder and residual anxiety","author":"Vitali","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"key-10.4103\/0253-7613.121390-4","first-page":"1401","volume-title":"Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death","author":"Patorno","year":"2010","journal-title":"JAMA"},{"key":"key-10.4103\/0253-7613.121390-5","first-page":"335","volume-title":"Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior","author":"Andersohn","year":"2010","journal-title":"Neurology"},{"key":"key-10.4103\/0253-7613.121390-6","first-page":"239","volume-title":"A method for estimating the probability of adverse drug reactions","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.4103\/0253-7613.121390-7","first-page":"1255","volume-title":"Adverse drug reactions: Definitions, diagnosis, and management","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"key-10.4103\/0253-7613.121390-8","first-page":"537","volume-title":"Suicide following deliberate self-harm: Long-term follow-up of patients who presented to a general hospital","author":"Hawton","year":"2003","journal-title":"Br J Psychiatry"},{"key":"key-10.4103\/0253-7613.121390-9","first-page":"123","volume-title":"Suicidality and antiepileptic drugs: Is there a link?","author":"Kalinin","year":"2007","journal-title":"Drug Saf"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:18:45Z","timestamp":1786648725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0253-7613.121390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"alternative-id":["121390"],"URL":"https:\/\/doi.org\/10.4103\/0253-7613.121390","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}